Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7336)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 6, 2019 (publication date) through Nov 12, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Thinn MM, Hsueh CT, Hsueh CT. Sustained complete response to erlotinib in squamous cell carcinoma of the head and neck: A case report. World J Clin Cases 2019; 7(5): 616-622 [PMID: 30863760 DOI: 10.12998/wjcc.v7.i5.616] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v7/i5/616.htm |
| Number | Citing Articles |
| 1 |
Dan Yu, Xueshibojie Liu, Guanghong Han, Yan Liu, Xue Zhao, Di Wang, Xiaomin Bian, Tingting Gu, Lianji Wen. The let-7 family of microRNAs suppresses immune evasion in head and neck squamous cell carcinoma by promoting PD-L1 degradation. Cell Communication and Signaling 2019; 17(1) doi: 10.1186/s12964-019-0490-8
|
| 2 |
Manuel Stöth, Till Meyer, Thomas Gehrke, Rudolf Hagen, Matthias Scheich, Stephan Hackenberg, Agmal Scherzad. Discontinuation of anti‑programmed cell death protein 1 immune checkpoint inhibition after complete remission in head and neck squamous cell carcinoma: A case report and literature review. Oncology Letters 2023; 26(5) doi: 10.3892/ol.2023.14076
|
| 3 |
Bharti Mangla, Priya Mittal, Pankaj Kumar, Geeta Aggarwal. Multifaceted role of erlotinib in various cancer: nanotechnology intervention, patent landscape, and advancements in clinical trials. Medical Oncology 2024; 41(7) doi: 10.1007/s12032-024-02414-5
|
| 4 |
Revathy Nadhan, Priya Srinivas, M. Radhakrishna Pillai. Receptor Tyrosine Kinases. Advances in Cancer Research 2020; 147: 319 doi: 10.1016/bs.acr.2020.04.008
|